- Home
- MNPR vs PHD Comparison
MNPR vs PHD Comparison
Compare MNPR & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- PHD
- Stock Information
- Founded
- MNPR 2014
- PHD 2004
- Country
- MNPR United States
- PHD United States
- Employees
- MNPR 12
- PHD N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- MNPR Health Care
- PHD Finance
- Exchange
- MNPR Nasdaq
- PHD Nasdaq
- Market Cap
- MNPR 292.9M
- PHD 121.9M
- IPO Year
- MNPR 2019
- PHD N/A
- Fundamental
- Price
- MNPR $48.50
- PHD $9.66
- Analyst Decision
- MNPR Strong Buy
- PHD
- Analyst Count
- MNPR 4
- PHD 0
- Target Price
- MNPR $43.00
- PHD N/A
- AVG Volume (30 Days)
- MNPR 67.7K
- PHD 67.7K
- Earning Date
- MNPR 03-27-2025
- PHD 01-01-0001
- Dividend Yield
- MNPR N/A
- PHD 11.43%
- EPS Growth
- MNPR N/A
- PHD N/A
- EPS
- MNPR N/A
- PHD 1.27
- Revenue
- MNPR N/A
- PHD N/A
- Revenue This Year
- MNPR N/A
- PHD N/A
- Revenue Next Year
- MNPR N/A
- PHD N/A
- P/E Ratio
- MNPR N/A
- PHD $7.60
- Revenue Growth
- MNPR N/A
- PHD N/A
- 52 Week Low
- MNPR $1.55
- PHD $8.30
- 52 Week High
- MNPR $49.98
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- MNPR 66.31
- PHD 46.67
- Support Level
- MNPR $34.41
- PHD $9.59
- Resistance Level
- MNPR $44.86
- PHD $9.71
- Average True Range (ATR)
- MNPR 5.69
- PHD 0.05
- MACD
- MNPR 1.13
- PHD 0.01
- Stochastic Oscillator
- MNPR 91.91
- PHD 65.75
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. Its investment objective is to provide a high level of current income and seek the preservation of capital by investing predominantly in floating-rate loans.